BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14466152)

  • 21. POLIOVIRUS: GUANIDINE DEPENDENCE AND LOSS OF NEUROVIRULENCE FOR MONKEYS.
    LODDO B; BROTZU G; SPANEDDA A; GESSA GL; FERRARI W
    Science; 1964 Aug; 145(3635):945-6. PubMed ID: 14163823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanidine conditioned infectivity of ribonucleic acid extracted from a strain of guanidine-dependent polio-1-virus.
    LODDO B; MUNTONI S; SPANEDDA A; BROTZU G; FERRARI W
    Nature; 1963 Jan; 197():315. PubMed ID: 13931211
    [No Abstract]   [Full Text] [Related]  

  • 23. THE ANTIVIRAL EFFECT OF GUANIDINE AND ITS DERIVATIVES: III. THE DEVELOPMENT OF GUANIDINE RESISTANT AND GUANIDINE DEPENDENT POLIO VIRUS IN TISSUE CULTURE.
    UEDA T; TOYOSHIMA S; SETO Y
    Keio J Med; 1963 Dec; 12():169-80. PubMed ID: 14112340
    [No Abstract]   [Full Text] [Related]  

  • 24. [ACTION OF GUANIDINE ON POLIOMYELITIS VIRUSES].
    BROTZU G; FERRARI W
    Rass Med Sarda; 1964; 67():35-46. PubMed ID: 14164047
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the inhibitory activity, in vitro, of guanidine towards poliomyelitis virus. XIII. Guanidine-dependence induced in vitro in poliomyelitis virus].
    LODDO B
    Boll Soc Ital Biol Sper; 1962 Nov; 38():1047. PubMed ID: 13931209
    [No Abstract]   [Full Text] [Related]  

  • 26. REGRESSION OF GUANIDINE-DEPENDENCE IN CLONED GUANIDINE-DEPENDENT POLIO VIRUSES.
    LODDO B; SPANEDDA A; BROTZU G; FERRARI W
    Life Sci (1962); 1963 Oct; 10():739-40. PubMed ID: 14076595
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the inhibitory activity, in vitro, of guanidine towards poliomyelitis virus. XII. Characterization of the guanidine-resistance induced in vitro in the poliomyelitis virus].
    LODDO B
    Boll Soc Ital Biol Sper; 1962 Nov; 38():1043-6. PubMed ID: 13931210
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibitory effect of guanidine on several viruses including polio and measles.
    TOYOSHIMA S; UEDA T; TSUJI T; SETO Y; NOMOTO J
    Chem Pharm Bull (Tokyo); 1963 Jan; 11():5-9. PubMed ID: 13993913
    [No Abstract]   [Full Text] [Related]  

  • 29. The antiviral effect of guanidine and its derivatives. II. The inhibitory effect of guanidine on several viruses including measies virus.
    UEDA T; TOYOSHIMA S; TSUJI T; SETO Y NOMOTO J
    Antibiot Chemother (Northfield); 1962 May; 12():330-6. PubMed ID: 13923489
    [No Abstract]   [Full Text] [Related]  

  • 30. [INHIBITING ACTIVITY IN VITRO OF PYRIMIDINO-GUANIDINE DERIVATIVES ON POLIOMYELITIS VIRUS].
    LODDO B; GARZIA A; FERRARI W
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1542-4. PubMed ID: 14122319
    [No Abstract]   [Full Text] [Related]  

  • 31. [2-(octahydro-1-azocinyl)-ethyl]-guanidine].
    JAQUES R; MEIER R
    Experientia; 1960 Feb; 16():75-6. PubMed ID: 14406799
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of guanidine on neuromuscular transmission.
    OTSUKA M; ENDO M
    J Pharmacol Exp Ther; 1960 Mar; 128():273-82. PubMed ID: 14429382
    [No Abstract]   [Full Text] [Related]  

  • 33. [RESEARCH "IN VITRO" ON THE ANTIPOLIOMYELITIC ACTIVITY OF GUANIDINE AND ON ITS CAPACITY TO INDURE A GUANIDINE-DEPENDENCE OF THE VIRUS].
    BROTZU G; FERRARI W; LODDO B; SPANEDDA A
    G Ital Chemioter; 1963; 10():1-23. PubMed ID: 14079388
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection against poliovirus paralysis by pretreatment with a guanidine-dependent poliovirus strain.
    LODDO B; SPANEDDA A; BROTZU G; FERRARI W
    Life Sci (1962); 1963 May; 5():331-3. PubMed ID: 13931219
    [No Abstract]   [Full Text] [Related]  

  • 35. [PROTECTION OF CERCOPITHECUS AETHIOPS AGAINST VIRULENT POLIOVIRUS BY INOCULATION WITH GUANIDINE-DEPENDENT POLIOVIRUS].
    LODDO B; FERRARI W; SPANEDDA A; BROTZU G
    Boll Soc Ital Biol Sper; 1963 Sep; 39():1003-4. PubMed ID: 14090492
    [No Abstract]   [Full Text] [Related]  

  • 36. [New research in the guanidine series and of quaternary ammonium salts].
    CHEYMOL J; LESPAGNOL A; DEBAERT M; ADOLPHE M; ADOLPHE C
    Therapie; 1961; 16():613-27. PubMed ID: 13878856
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of proteolytic enzymes by decarboxylated amino-acid derivatives. Effect of toluenesulphonyl(tosyl)agmatine (4-toluenesulphonamidobutyl-guanidine) on thrombin trypsin.
    LORAND L; RULE NG
    Nature; 1961 May; 190():722-3. PubMed ID: 13763480
    [No Abstract]   [Full Text] [Related]  

  • 38. [Protection of the monkey against experimental poliovirus infection by means of preventive inoculation of guanidine-dependent virus].
    LODDO B; FERRARI W; BROTZU G; SPANEDDA A
    Rass Med Sarda; 1963; 65():215-9. PubMed ID: 13931208
    [No Abstract]   [Full Text] [Related]  

  • 39. ANTI-VIRAL ACTIVITY OF TWO GUANIDINE DERIVATIVES IN VITRO.
    LODDO B; GESSA GL
    Nature; 1965 Jan; 205():401-2. PubMed ID: 14243432
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypotensive action and effects on sodium-potassium diuresis of a new drug derived from guanidine].
    ZUCCHELLI GP; MATERAZZI F
    Minerva Med; 1960 Dec; 51():4194-6. PubMed ID: 13788862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.